Biomarkers Consortium Resources

Submission Resources

Click here for information on how to electronically submit a Letter of Intent (LOI), Qualification Plan (QP) or Full Qualification Package (FQP).

The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction. Menetski J, Hoffmann S, Cush S, Kamphaus T, Austin C, Herrling P, Wagner J. Clinical Pharmacology & Therapeutics Volume 105(4). 2019 April.
The FNIH Biomarkers Consortium embraces the BEST. Menetski J, Austin C, Brady L, Eakin G, Leptak C, Meltzer A, Wagner J. Nature Reviews Drug Discovery. 2019, Feb.
Evaluation of Wearable Digital Devices in a Phase I Clinical Trial. Izmallova E, McLean I, Bhatta G, Hather G, Cantor M, Merberg D, Perakslis E, Benko C, Wagner J. Clin Transl Sci, 2018
Patient-centered activity monitoring in the self-management of chronic health conditions. Chiauzzi E, Rodarte C, DasMahapatra P. BMC Medicine. 2015.13(77)

American Society for Clinical Pharmacology & Therapeutics (ASCPT): "How To Develop and Qualify Biomarkers: Biomarker Consortium Perspective"
Speaker: Joseph P. Menetski, Ph.D., Associate Vice President of Research Partnerships, FNIH

FNIH Biomarkers Consortium - Beta Cell Project
"A New Tool for Diabetes Research"